The expression of IL-13Rα2 mRNA and protein was also further increased in DU145 and PC-3 cell lines after TSA or 5-aza-dC treatment, indicating that IL-13Rα2 expression is epigenetically regulated in prostate cancer cell lines. This evidence concerns the gene IL13RA2 and prostate carcinoma.